Skip to content
AnalystLens

Leidos Holdings Annual Report, Year Ended Jan 2, 2026

Filing Date
Filed February 17, 2026
Period End
January 2, 2026
Security
LDOS
One revenue dollarkept$0.08
In the record · 2016–202610-K1210-Q338-K130

LDOS filed 12 annual reports (10-K), 33 quarterly reports (10-Q) and 130 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Aug ’18Aug ’18
  2. Leadership change8-K · Oct ’20Oct ’20
  3. Leadership change8-K · Feb ’23Feb ’23
  4. Material agreement8-K · Feb ’25Feb ’25

Summary

Summary of the 10-K filed February 17, 2026. Cited figures are marked; the original filing is the authoritative source.

Leidos Holdings, Inc. ("Leidos") reported fiscal 2025 (ended January 2, 2026) revenues of $17,174 milliona, up 3% from $16,662 million in fiscal 2024, with operating income of $2,109 million (operating margin of 12.3%, versus 11.0% in fiscal 2024) and net income attributable to common stockholders of $1,448 million, compared with $1,254 million a year earlier.

Diluted EPS was $11.14b, versus $9.22. The company states that 87% of revenues came from U.S. government contracts, and approximately 49% came from contracts with the DoW and U.S. Intelligence Community. Total backlog was $49,032 million, including $9,685 million funded, versus $48,390 million a year earlier.

Cash flow from operations was $1,750 millionc, up from $1,435 million, which the company attributes mainly to tax benefits from the One Big Beautiful Bill Act and favorable working capital changes. The company ended the year with $1,108 million of cash and cash equivalents and $4.6 billion of debt. Leidos repurchased $944 million of stock in financing activities and paid $211 million in dividends, with dividends declared at $1.63 per share for the year.

On January 23, 2026, the company agreed to acquire Entrust (KENE Parent, Inc.) for $2.4 billiond in cash, funded in part by a $1.4 billion 364-day bridge facility, and on February 12, 2026 it raised its revolving credit facility to $1.5 billion from $1.0 billion. The filing also flags several risks, including U.S. government budget uncertainty and continuing resolutions, bid protests and competitive pricing pressure, contract termination rights, an open DOJ Antitrust Division grand jury subpoena related to three 2021 and 2022 procurements, and the Executive Order "Prioritizing the Warfighter in Defense Contracting," which may restrict buybacks, dividends and executive incentive pay on future contracts. The company also plans to realign into four new reportable segments starting in fiscal 2026.

Key Highlights

  1. Revenue of $17,174 million for fiscal 2025, up 3% from $16,662 million; operating income of $2,109 million, up from $1,827 million, with operating margin of 12.3% versus 11.0%.
  2. Net income attributable to Leidos common stockholders of $1,448 million, up from $1,254 million; diluted EPS of $11.14 versus $9.22.
  3. Total backlog of $49,032 million at year-end, including $9,685 million funded, up from $48,390 million; net bookings were $17.5 billion versus $23.2 billion in fiscal 2024.
  4. Operating cash flow of $1,750 million, up from $1,435 million, driven mainly by OBBBA tax benefits and working capital changes.
  5. Agreed on January 23, 2026 to acquire Entrust for $2.4 billion in cash, financed in part by a $1.4 billion 364-day bridge facility; the revolving credit facility was increased to $1.5 billion on February 12, 2026.
  6. Health & Civil segment operating margin rose to 23.7% from 21.8%, while Commercial & International margin rose to 7.2% from 4.6%.
  7. A federal grand jury subpoena from the DOJ Antitrust Division related to three 2021 and 2022 procurements remains under investigation, and the company is cooperating.

Follow one dollar

Of each $1.00 of revenue in FY2026, Leidos Holdings kept $0.08.

  1. Revenue$17.11B100.0%
  2. Cost of revenue−$14.07B82.3%
  3. Gross profit$3.03B17.7%
  4. Operating costs−$923.0M5.4%
  5. Operating income$2.11B12.3%
  6. Interest, other & tax−$661.0M3.9%
  7. Net income$1.45B8.5%
Computed from 10-KFY2026filed February 17, 2026Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Financial Statements

FY2026 against FY2025

Line itemFY2026FY2025Change
Revenue$17.11B$16.58B+3.2%
Cost of Revenue$14.07B$13.86B+1.5%
Gross Profit$3.03B$2.71B+11.8%
R&D Expenses$187.00M$150.00M+24.7%
SG&A Expenses$999.00M$983.00M+1.6%
Operating Income$2.11B$1.83B+15.4%
Net Income$1.45B$1.25B+15.5%
EPS (Basic)$11.31$9.36+20.8%
EPS (Diluted)$11.14$9.22+20.8%
Shares Outstanding (Basic)128.00M134.00M−4.5%
Shares Outstanding (Diluted)130.00M136.00M−4.4%

Frequently Asked Questions

  1. How much of Leidos's revenue depends on the U.S. government?

    The filing states that approximately 87% of revenues in fiscal 2025 came from U.S. government contracts, either as a prime contractor or a subcontractor. Revenues from contracts with the DoW and U.S. Intelligence Community were approximately 49% of total revenues for fiscal 2025.

  2. What drove the change in operating income?

    Operating income increased to $2,109 million from $1,827 million. The company attributes the increase mainly to program wins and a net increase in volumes on certain programs, partially offset by higher general and administrative expenses and program completions.

  3. What is the status of the Entrust acquisition and how is it financed?

    On January 23, 2026, Leidos, Inc. agreed to acquire all shares of Entrust for $2.4 billion in cash, subject to customary adjustments. The company entered into a $1.4 billion senior unsecured 364-day bridge loan facility with Citigroup Global Markets Inc. The transaction is expected to close in the first half of fiscal 2026, subject to customary closing conditions.

  4. What capital returns did Leidos make in fiscal 2025?

    Dividends paid totaled $211 million, and dividends declared were $1.63 per share, up from $1.54. Repurchases of stock and other were $944 million in cash flows, including a $500 million accelerated share repurchase, and $400 million of open market repurchases. The filing also notes that the executive order on defense contracting could restrict future stock buybacks and dividends during periods of underperformance.

  5. What regulatory or legal risks does the filing highlight?

    The filing discusses the risk of government contract terminations for convenience, bid protests, audits by the DCAA, and the executive order on defense contracting, which may restrict buybacks, dividends and executive incentive pay. It also notes a federal grand jury subpoena from the DOJ Antitrust Division concerning three procurements, which the company is cooperating with, and it says it cannot yet determine whether fines or other liabilities will result.